AKT represents a main molecular target of the PD-1 inhibitory activity in T lymphocytes [255,256] and determines a polyfunctional phenotype in Ag-specific CD8+ T cells derived from the peripheral blood of melanoma patients [257]. The gene discussed is CD8A; the disease is melanoma.